메뉴 건너뛰기




Volumn 8, Issue 8, 2013, Pages

New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Author keywords

[No Author keywords available]

Indexed keywords

1,2,6,7 TETRAOXASPIRO[7.11]NONADECANE; 6(1,2,6,7 TETRAOXASPIRO[7.11]NONADEC 4 YL)HEXAN 1 OL; ALPHA INTERFERON; ALPHA TOCOPHEROL; ANTIMALARIAL AGENT; N 251; N 89; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

EID: 84883408971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072519     Document Type: Article
Times cited : (8)

References (42)
  • 2
    • 0035379237 scopus 로고    scopus 로고
    • Molecular virology of hepatitis C virus
    • Kato N, (2001) Molecular virology of hepatitis C virus. Acta Med Okayama 55: 133-159.
    • (2001) Acta Med Okayama , vol.55 , pp. 133-159
    • Kato, N.1
  • 3
    • 0025685188 scopus 로고
    • Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
    • Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, et al. (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87: 9524-9528.
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 9524-9528
    • Kato, N.1    Hijikata, M.2    Ootsuyama, Y.3    Nakagawa, M.4    Ohkoshi, S.5
  • 4
    • 35649014170 scopus 로고    scopus 로고
    • Interferon-based therapy of hepatitis C
    • Chevaliez S, Pawlotsky JM, (2007) Interferon-based therapy of hepatitis C. Adv Drug Deliv Rev. 59: 1222-1241.
    • (2007) Adv Drug Deliv Rev , vol.59 , pp. 1222-1241
    • Chevaliez, S.1    Pawlotsky, J.M.2
  • 5
    • 80053339008 scopus 로고    scopus 로고
    • An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
    • Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB, (2011) An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54: 1433-1444.
    • (2011) Hepatology , vol.54 , pp. 1433-1444
    • Ghany, M.G.1    Nelson, D.R.2    Strader, D.B.3    Thomas, D.L.4    Seeff, L.B.5
  • 8
    • 33749360242 scopus 로고    scopus 로고
    • Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study
    • Reesink HW, Zeuzem S, Weegink CJ, Forestier N, van Vliet A, et al. (2006) Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. Gastroenterology 131: 997-1002.
    • (2006) Gastroenterology , vol.131 , pp. 997-1002
    • Reesink, H.W.1    Zeuzem, S.2    Weegink, C.J.3    Forestier, N.4    van Vliet, A.5
  • 9
    • 73149113353 scopus 로고    scopus 로고
    • Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
    • Susser S, Welsch C, Wang Y, Zettler M, Domingues FS, et al. (2009) Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology 50: 1709-1718.
    • (2009) Hepatology , vol.50 , pp. 1709-1718
    • Susser, S.1    Welsch, C.2    Wang, Y.3    Zettler, M.4    Domingues, F.S.5
  • 10
    • 79959478969 scopus 로고    scopus 로고
    • Clinical practice. Chronic hepatitis C infection
    • Rosen HR, (2011) Clinical practice. Chronic hepatitis C infection. N Engl J Med 364: 2429-2438.
    • (2011) N Engl J Med , vol.364 , pp. 2429-2438
    • Rosen, H.R.1
  • 11
    • 79955103901 scopus 로고    scopus 로고
    • Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
    • Pawlotsky JM, (2011) Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 53: 1742-1751.
    • (2011) Hepatology , vol.53 , pp. 1742-1751
    • Pawlotsky, J.M.1
  • 12
    • 34447296186 scopus 로고    scopus 로고
    • Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
    • Bartenschlager R, Sparacio S, (2007) Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 127: 195-207.
    • (2007) Virus Res , vol.127 , pp. 195-207
    • Bartenschlager, R.1    Sparacio, S.2
  • 13
    • 16244394753 scopus 로고    scopus 로고
    • Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system
    • Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, et al. (2005) Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329: 1350-1359.
    • (2005) Biochem Biophys Res Commun , vol.329 , pp. 1350-1359
    • Ikeda, M.1    Abe, K.2    Dansako, H.3    Nakamura, T.4    Naka, K.5
  • 14
    • 35648972113 scopus 로고    scopus 로고
    • Modulation of host metabolism as a target of new antivirals
    • Ikeda M, Kato N, (2007) Modulation of host metabolism as a target of new antivirals. Adv Drug Deliv Rev 59: 1277-1289.
    • (2007) Adv Drug Deliv Rev , vol.59 , pp. 1277-1289
    • Ikeda, M.1    Kato, N.2
  • 16
    • 16244415552 scopus 로고    scopus 로고
    • Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha
    • Naka K, Ikeda M, Abe K, Dansako H, Kato N, (2005) Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha. Biochem Biophys Res Commun 330: 871-879.
    • (2005) Biochem Biophys Res Commun , vol.330 , pp. 871-879
    • Naka, K.1    Ikeda, M.2    Abe, K.3    Dansako, H.4    Kato, N.5
  • 17
    • 33745903898 scopus 로고    scopus 로고
    • Different anti-HCV profiles of statins and their potential for combination therapy with interferon
    • Ikeda M, Abe K, Yamada M, Dansako H, Naka K, et al. (2006) Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44: 117-125.
    • (2006) Hepatology , vol.44 , pp. 117-125
    • Ikeda, M.1    Abe, K.2    Yamada, M.3    Dansako, H.4    Naka, K.5
  • 18
    • 77950601184 scopus 로고    scopus 로고
    • Hydroxyurea as an inhibitor of hepatitis C virus RNA replication
    • Nozaki A, Morimoto M, Kondo M, Oshima T, Numata K, et al. (2010) Hydroxyurea as an inhibitor of hepatitis C virus RNA replication. Arch Virol 155: 601-605.
    • (2010) Arch Virol , vol.155 , pp. 601-605
    • Nozaki, A.1    Morimoto, M.2    Kondo, M.3    Oshima, T.4    Numata, K.5
  • 19
    • 79958071893 scopus 로고    scopus 로고
    • Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C
    • Ikeda M, Kawai Y, Mori K, Yano M, Abe K, et al. (2011) Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C. Liver Int. 31: 871-880.
    • (2011) Liver Int , vol.31 , pp. 871-880
    • Ikeda, M.1    Kawai, Y.2    Mori, K.3    Yano, M.4    Abe, K.5
  • 20
    • 70350233422 scopus 로고    scopus 로고
    • Efficient replication systems for hepatitis C virus using a new human hepatoma cell line
    • Kato N, Mori K, Abe K, Dansako H, Kuroki M, et al. (2009) Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. Virus Res 146: 41-50.
    • (2009) Virus Res , vol.146 , pp. 41-50
    • Kato, N.1    Mori, K.2    Abe, K.3    Dansako, H.4    Kuroki, M.5
  • 21
    • 78649872069 scopus 로고    scopus 로고
    • Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: Comparison with HuH-7 and other hepatic cell lines
    • Mori K, Ikeda M, Ariumi Y, Kato N, (2010) Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: Comparison with HuH-7 and other hepatic cell lines. Hepatol Res 40: 1248-1253.
    • (2010) Hepatol Res , vol.40 , pp. 1248-1253
    • Mori, K.1    Ikeda, M.2    Ariumi, Y.3    Kato, N.4
  • 22
    • 79953025461 scopus 로고    scopus 로고
    • Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system
    • Mori K, Ikeda M, Ariumi Y, Dansako H, Wakita T, et al. (2011) Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. Virus Res 157: 61-70.
    • (2011) Virus Res , vol.157 , pp. 61-70
    • Mori, K.1    Ikeda, M.2    Ariumi, Y.3    Dansako, H.4    Wakita, T.5
  • 23
    • 84884981804 scopus 로고    scopus 로고
    • Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin
    • in press
    • Mori K, Hiraoka O, Ikeda M, Ariumi Y, Hiramoto A, et al. (2013) Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin. Hepatology in press.
    • (2013) Hepatology
    • Mori, K.1    Hiraoka, O.2    Ikeda, M.3    Ariumi, Y.4    Hiramoto, A.5
  • 24
    • 79959283124 scopus 로고    scopus 로고
    • Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents
    • Ueda Y, Mori K, Ariumi Y, Ikeda M, Kato N, (2011) Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents. Biochem Biophys Res Commun 409: 663-668.
    • (2011) Biochem Biophys Res Commun , vol.409 , pp. 663-668
    • Ueda, Y.1    Mori, K.2    Ariumi, Y.3    Ikeda, M.4    Kato, N.5
  • 26
    • 0035811454 scopus 로고    scopus 로고
    • Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes
    • Kim HS, Nagai Y, Ono K, Begum K, Wataya Y, et al. (2001) Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem 44: 2357-2361.
    • (2001) J Med Chem , vol.44 , pp. 2357-2361
    • Kim, H.S.1    Nagai, Y.2    Ono, K.3    Begum, K.4    Wataya, Y.5
  • 27
    • 79959523974 scopus 로고    scopus 로고
    • Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol
    • Sato A, Hiramoto A, Morita M, Matsumoto M, Komich Y, et al. (2011) Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol. Parasitol Int 60: 270-273.
    • (2011) Parasitol Int , vol.60 , pp. 270-273
    • Sato, A.1    Hiramoto, A.2    Morita, M.3    Matsumoto, M.4    Komich, Y.5
  • 28
    • 82155172896 scopus 로고    scopus 로고
    • Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives
    • Sato A, Kawai S, Hiramoto A, Morita M, Tanigawa N, et al. (2011) Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives. Parasitol Int 60: 488-492.
    • (2011) Parasitol Int , vol.60 , pp. 488-492
    • Sato, A.1    Kawai, S.2    Hiramoto, A.3    Morita, M.4    Tanigawa, N.5
  • 29
    • 84862667513 scopus 로고    scopus 로고
    • Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines
    • Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N, (2012) Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines. J Gen Virol 93: 1422-1431.
    • (2012) J Gen Virol , vol.93 , pp. 1422-1431
    • Takeda, M.1    Ikeda, M.2    Ariumi, Y.3    Wakita, T.4    Kato, N.5
  • 30
    • 84863718301 scopus 로고    scopus 로고
    • Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C
    • Mori K, Ueda Y, Ariumi Y, Dansako H, Ikeda M, et al. (2012) Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C. Virus Genes. 44: 374-381.
    • (2012) Virus Genes , vol.44 , pp. 374-381
    • Mori, K.1    Ueda, Y.2    Ariumi, Y.3    Dansako, H.4    Ikeda, M.5
  • 31
    • 62049083765 scopus 로고    scopus 로고
    • Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents
    • Nishimura G, Ikeda M, Mori K, Nakazawa T, Ariumi Y, et al. (2009) Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents. Antiviral Res 82: 42-50.
    • (2009) Antiviral Res , vol.82 , pp. 42-50
    • Nishimura, G.1    Ikeda, M.2    Mori, K.3    Nakazawa, T.4    Ariumi, Y.5
  • 32
    • 0041630597 scopus 로고    scopus 로고
    • Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro
    • Kato N, Sugiyama K, Namba K, Dansako H, Nakamura T, et al. (2003) Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306: 756-766.
    • (2003) Biochem Biophys Res Commun , vol.306 , pp. 756-766
    • Kato, N.1    Sugiyama, K.2    Namba, K.3    Dansako, H.4    Nakamura, T.5
  • 33
    • 33847624986 scopus 로고    scopus 로고
    • Proteome analysis of new antimalarial endoperoxide against Plasmodium falciparum
    • Aly NS, Hiramoto A, Sanai H, Hiraoka O, Hiramoto K, et al. (2007) Proteome analysis of new antimalarial endoperoxide against Plasmodium falciparum. Parasitol Res 100: 1119-1124.
    • (2007) Parasitol Res , vol.100 , pp. 1119-1124
    • Aly, N.S.1    Hiramoto, A.2    Sanai, H.3    Hiraoka, O.4    Hiramoto, K.5
  • 34
    • 0038416107 scopus 로고    scopus 로고
    • Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes
    • Kim HS, Begum K, Ogura N, Wataya Y, Nonami Y, et al. (2003) Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes. J Med Chem 46: 1957-1961.
    • (2003) J Med Chem , vol.46 , pp. 1957-1961
    • Kim, H.S.1    Begum, K.2    Ogura, N.3    Wataya, Y.4    Nonami, Y.5
  • 35
    • 46349106552 scopus 로고    scopus 로고
    • New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C
    • Mori K, Abe K, Dansako H, Ariumi Y, Ikeda M, et al. (2008) New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C. Biochem Biophys Res Commun. 371: 104-109.
    • (2008) Biochem Biophys Res Commun , vol.371 , pp. 104-109
    • Mori, K.1    Abe, K.2    Dansako, H.3    Ariumi, Y.4    Ikeda, M.5
  • 36
    • 33947136220 scopus 로고    scopus 로고
    • Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA
    • Abe K, Ikeda M, Dansako H, Naka K, Kato N, (2007) Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Res 125: 88-97.
    • (2007) Virus Res , vol.125 , pp. 88-97
    • Abe, K.1    Ikeda, M.2    Dansako, H.3    Naka, K.4    Kato, N.5
  • 37
    • 34250202525 scopus 로고    scopus 로고
    • Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture
    • Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, et al. (2007) Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother 51: 2016-2027.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 2016-2027
    • Yano, M.1    Ikeda, M.2    Abe, K.3    Dansako, H.4    Ohkoshi, S.5
  • 38
    • 70349229385 scopus 로고    scopus 로고
    • Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase
    • Yano M, Ikeda M, Abe K, Kawai Y, Kuroki M, et al. (2009) Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase. Hepatology 50: 678-688.
    • (2009) Hepatology , vol.50 , pp. 678-688
    • Yano, M.1    Ikeda, M.2    Abe, K.3    Kawai, Y.4    Kuroki, M.5
  • 40
    • 23944506014 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis C virus infection
    • Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
    • (2005) Lancet Infect Dis , vol.5 , pp. 558-567
    • Shepard, C.W.1    Finelli, L.2    Alter, M.J.3
  • 41
    • 84870884133 scopus 로고    scopus 로고
    • Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251
    • Morita M, Sanai H, Hiramoto A, Sato A, Hiraoka O, et al. (2012) Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251. J Proteome Res 11: 5704-5711.
    • (2012) J Proteome Res , vol.11 , pp. 5704-5711
    • Morita, M.1    Sanai, H.2    Hiramoto, A.3    Sato, A.4    Hiraoka, O.5
  • 42
    • 84878173326 scopus 로고    scopus 로고
    • Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
    • in press
    • Rotman Y, Noureddin M, Feld JJ, Guedj J, Witthaus M, et al. (2013) Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut in press.
    • (2013) Gut
    • Rotman, Y.1    Noureddin, M.2    Feld, J.J.3    Guedj, J.4    Witthaus, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.